ASEAN - Human Blood and Animal Blood Prepared for Therapeutic, Pophylactic or Diagnostic Uses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingASEAN: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024
Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in ASEAN
The ASEAN human and animal blood market contracted to $X in 2023, which is down by X% against the previous year. Over the period under review, consumption saw pronounced growth. Over the period under review, the market reached the maximum level at $X in 2022, and then shrank in the following year.
Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in ASEAN
In value terms, human and animal blood production stood at $X in 2023 estimated in export price. In general, production posted resilient growth. The most prominent rate of growth was recorded in 2020 with an increase of X% against the previous year. The level of production peaked at $X in 2021; however, from 2022 to 2023, production failed to regain momentum.
Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses
Exports in ASEAN
In 2023, the amount of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exported in ASEAN soared to X tons, increasing by X% compared with 2022. Over the period under review, exports continue to indicate noticeable growth. The growth pace was the most rapid in 2020 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2021; however, from 2022 to 2023, the exports stood at a somewhat lower figure.
In value terms, human and animal blood exports reduced to $X in 2023. Overall, exports posted buoyant growth. The growth pace was the most rapid in 2020 with an increase of X% against the previous year. The level of export peaked at $X in 2021; however, from 2022 to 2023, the exports failed to regain momentum.
Exports by Country
In 2023, Singapore (X tons) represented the key exporter of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, committing X% of total exports. Thailand (X tons) ranks second in terms of the total exports with a X% share, followed by Vietnam (X%).
Exports from Singapore increased at an average annual rate of X% from 2012 to 2023. At the same time, Vietnam (X%) displayed positive paces of growth. Moreover, Vietnam emerged as the fastest-growing exporter exported in ASEAN, with a CAGR of X% from 2012-2023. By contrast, Thailand (X%) illustrated a downward trend over the same period. Singapore (X p.p.) and Vietnam (X p.p.) significantly strengthened its position in terms of the total exports, while Thailand saw its share reduced by X% from 2012 to 2023, respectively.
In value terms, Singapore ($X) remains the largest human and animal blood supplier in ASEAN, comprising X% of total exports. The second position in the ranking was taken by Thailand ($X), with a X% share of total exports.
In Singapore, human and animal blood exports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Thailand (X% per year) and Vietnam (X% per year).
Export Prices by Country
In 2023, the export price in ASEAN amounted to $X per ton, declining by X% against the previous year. Overall, the export price, however, enjoyed a buoyant increase. The most prominent rate of growth was recorded in 2015 an increase of X% against the previous year. The level of export peaked at $X per ton in 2020; however, from 2021 to 2023, the export prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major exporting countries. In 2023, amid the top suppliers, the country with the highest price was Singapore ($X per ton), while Vietnam ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Singapore (X%), while the other leaders experienced mixed trends in the export price figures.
Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses
Imports in ASEAN
In 2023, supplies from abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses was finally on the rise to reach X tons for the first time since 2020, thus ending a two-year declining trend. In general, imports posted strong growth. As a result, imports reached the peak and are likely to continue growth in the immediate term.
In value terms, human and animal blood imports skyrocketed to $X in 2023. Over the period under review, imports enjoyed prominent growth. As a result, imports attained the peak and are likely to continue growth in the immediate term.
Imports by Country
Brunei Darussalam prevails in imports structure, resulting at X tons, which was near X% of total imports in 2023. Malaysia (X tons) held an X% share (based on physical terms) of total imports, which put it in second place, followed by Vietnam (X%). Singapore (X tons), Thailand (X tons), the Philippines (X tons) and Indonesia (X tons) followed a long way behind the leaders.
Brunei Darussalam was also the fastest-growing in terms of the human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses imports, with a CAGR of X% from 2012 to 2023. At the same time, Malaysia (X%), the Philippines (X%), Vietnam (X%), Thailand (X%) and Indonesia (X%) displayed positive paces of growth. By contrast, Singapore (X%) illustrated a downward trend over the same period. While the share of Brunei Darussalam (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of Thailand (X p.p.), Indonesia (X p.p.) and Singapore (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.
In value terms, Brunei Darussalam ($X) constitutes the largest market for imported human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses in ASEAN, comprising X% of total imports. The second position in the ranking was held by Thailand ($X), with an X% share of total imports. It was followed by Vietnam, with a X% share.
In Brunei Darussalam, human and animal blood imports increased at an average annual rate of X% over the period from 2012-2023. The remaining importing countries recorded the following average annual rates of imports growth: Thailand (X% per year) and Vietnam (X% per year).
Import Prices by Country
In 2023, the import price in ASEAN amounted to $X per ton, which is down by X% against the previous year. Overall, the import price recorded a deep reduction. The growth pace was the most rapid in 2017 an increase of X% against the previous year. Over the period under review, import prices reached the peak figure at $X per ton in 2013; however, from 2014 to 2023, import prices stood at a somewhat lower figure.
Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Brunei Darussalam ($X per ton), while Indonesia ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Brunei Darussalam (X%), while the other leaders experienced mixed trends in the import price figures.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for human and animal blood in ASEAN. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21106055 - Human blood, animal blood prepared for therapeutic, p rophylactic or diagnostic uses, cultures of micro-organisms, t oxins (excluding yeasts)
Country coverage:
- Brunei Darussalam
- Cambodia
- Indonesia
- Lao People's Democratic Republic
- Malaysia
- Myanmar
- Philippines
- Singapore
- Thailand
- Vietnam
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Production in ASEAN, split by region and country
- Trade (exports and imports) in ASEAN
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- CONSUMPTION BY COUNTRY
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
- PRODUCTION BY COUNTRY
8. IMPORTS
The Largest Importers on The Market and How They Succeed
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Exporters on The Market and How They Succeed
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- Brunei Darussalam
- Cambodia
- Indonesia
- Malaysia
- Myanmar
- Philippines
- Singapore
- Thailand
- Vietnam
- Lao People's Democratic Republic
-
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption, By Country, 2018–2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Destination, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Origin, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Consumption, By Country, 2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Production, By Country, 2023
- Production, In Physical Terms, By Country, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for human and animal blood in Asia.
This report provides an in-depth analysis of the market for human and animal blood in the U.S..
This report provides an in-depth analysis of the market for human and animal blood in China.
This report provides an in-depth analysis of the market for human and animal blood in the EU.
This report provides an in-depth analysis of the global market for human and animal blood.